CVS
CVS Health Corp
NYSE: CVS · HEALTHCARE · HEALTHCARE PLANS
$83.90
+3.61% today
Updated 2026-04-29
Market cap
$107.53B
P/E ratio
60.36
P/S ratio
0.27x
EPS (TTM)
$1.39
Dividend yield
3.28%
52W range
$56 – $84
Volume
7.7M
CVS Health Corp (CVS) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $43.82B | $76.33B | $87.47B | $98.22B | $95.78B | $107.08B | $123.12B | $126.76B | $139.37B | $153.29B | $177.55B | $184.79B | $194.58B | $256.78B | $268.71B | $292.11B | $322.47B | $357.78B | $372.81B | $402.07B |
| Revenue growth (YoY) | — | +74.2% | +14.6% | +12.3% | -2.5% | +11.8% | +15.0% | +3.0% | +9.9% | +10.0% | +15.8% | +4.1% | +5.3% | +32.0% | +4.6% | +8.7% | +10.4% | +10.9% | +4.2% | +7.8% |
| Cost of revenue | $32.08B | $60.22B | $69.18B | $77.86B | $75.56B | $86.52B | $100.63B | $102.98B | $114.00B | $126.76B | $148.71B | $156.26B | $163.04B | $211.25B | $219.66B | $239.99B | $267.96B | $303.35B | $321.41B | $346.70B |
| Gross profit | $11.74B | $16.11B | $18.29B | $20.36B | $20.22B | $20.56B | $22.49B | $23.78B | $25.37B | $26.53B | $28.83B | $28.53B | $31.54B | $45.53B | $49.05B | $52.12B | $54.50B | $54.43B | $51.40B | $55.36B |
| Gross margin | 26.8% | 21.1% | 20.9% | 20.7% | 21.1% | 19.2% | 18.3% | 18.8% | 18.2% | 17.3% | 16.2% | 15.4% | 16.2% | 17.7% | 18.3% | 17.8% | 16.9% | 15.2% | 13.8% | 13.8% |
| R&D | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| SG&A | $8.76B | $11.23B | $12.24B | $13.94B | $14.09B | $14.23B | $15.06B | $15.64B | $16.33B | $16.63B | $18.06B | $18.29B | $20.38B | $32.23B | $34.46B | $36.23B | $37.18B | $38.36B | $40.24B | $970.00M |
| Operating income | $2.44B | $4.79B | $6.05B | $6.42B | $6.14B | $6.33B | $7.21B | $8.04B | $8.80B | $9.47B | $10.39B | $9.54B | $4.02B | $11.99B | $13.91B | $13.31B | $7.95B | $13.74B | $8.52B | $10.38B |
| Operating margin | 5.6% | 6.3% | 6.9% | 6.5% | 6.4% | 5.9% | 5.9% | 6.3% | 6.3% | 6.2% | 5.8% | 5.2% | 2.1% | 4.7% | 5.2% | 4.6% | 2.5% | 3.8% | 2.3% | 2.6% |
| EBITDA | $3.17B | $5.89B | $7.34B | $7.82B | $7.61B | $7.90B | $8.62B | $9.91B | $10.22B | $11.57B | $12.19B | $11.81B | $6.74B | $16.40B | $17.12B | $17.53B | $12.35B | $13.74B | $13.68B | $9.86B |
| EBITDA margin | 7.2% | 7.7% | 8.4% | 8.0% | 7.9% | 7.4% | 7.0% | 7.8% | 7.3% | 7.5% | 6.9% | 6.4% | 3.5% | 6.4% | 6.4% | 6.0% | 3.8% | 3.8% | 3.7% | 2.5% |
| EBIT | $2.44B | $4.79B | $6.07B | $6.43B | $6.14B | $6.33B | $6.87B | $8.04B | $8.29B | $9.47B | $9.71B | $9.33B | $4.03B | $12.03B | $12.68B | $13.04B | $8.12B | $13.74B | $9.09B | $5.25B |
| Interest expense | $216.00M | $435.00M | $530.00M | $530.00M | $539.00M | $588.00M | $561.00M | $517.00M | $615.00M | $859.00M | $1.08B | $1.06B | $2.62B | $3.04B | $2.91B | $2.50B | $2.29B | $2.66B | $2.96B | $3.12B |
| Income tax | $856.90M | $1.72B | $2.19B | $2.20B | $2.18B | $2.26B | $2.44B | $2.93B | $3.03B | $3.39B | $3.32B | $1.64B | $2.00B | $2.37B | $2.57B | $2.55B | $1.51B | $2.81B | $1.56B | $408.00M |
| Effective tax rate | 38.5% | 39.5% | 40.6% | 37.3% | 38.9% | 39.5% | 38.7% | 38.9% | 39.5% | 39.3% | 38.4% | 19.8% | 142.2% | 26.3% | 26.4% | 24.2% | 25.9% | 25.2% | 25.3% | 18.8% |
| Net income | $1.37B | $2.64B | $3.21B | $3.70B | $3.43B | $3.46B | $3.86B | $4.59B | $4.64B | $5.24B | $5.32B | $6.62B | $-594.00M | $6.63B | $7.18B | $8.00B | $4.31B | $8.34B | $4.61B | $1.77B |
| Net income growth (YoY) | — | +92.6% | +21.8% | +15.1% | -7.3% | +1.0% | +11.6% | +18.8% | +1.1% | +12.8% | +1.5% | +24.5% | -109.0% | +1216.8% | +8.2% | +11.5% | -46.1% | +93.6% | -44.7% | -61.7% |
| Profit margin | 3.1% | 3.5% | 3.7% | 3.8% | 3.6% | 3.2% | 3.1% | 3.6% | 3.3% | 3.4% | 3.0% | 3.6% | -0.3% | 2.6% | 2.7% | 2.7% | 1.3% | 2.3% | 1.2% | 0.4% |